Philips to Invest $150M in U.S. Manufacturing and R&D Expansion

The company said the expansion will add 24,000 square feet of manufacturing space and 40,000 square feet of warehouse space, creating an estimated 120 skilled manufacturing jobs.

Philips has announced plans to invest over $150 million in U.S. manufacturing, research, and development, targeting expansions at its facilities in Reedsville, Pennsylvania, and Plymouth, Minnesota.

The Reedsville site, which currently manufactures transducers, will broaden its operations to include software customization and configurations of ultrasound systems tailored for cardiovascular, general, and maternal care. 

The company said the expansion will add 24,000 square feet of manufacturing space and 40,000 square feet of warehouse space, creating an estimated 120 skilled manufacturing jobs.

Similarly, the Image Guided Therapy facility will grow in Plymouth, including the construction of a new medtech training center. Philips expects this expansion to generate over 150 new jobs. The announcement builds on the company’s annual research and development investment of $900 million in the United States.

Philips, headquartered in the Netherlands, provides diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics. The company employs roughly 17,000 people across 40 U.S. facilities.

Stock market sentiment around Philips (PHG) has shown movement recently. Retail sentiment shifted from bearish to neutral on Stocktwits over 24 hours, while message volume remained low. PHG shares are up approximately 7% year-to-date but have fallen about 5% over the past 12 months.

The expansions reflect Philips’ focus on strengthening domestic manufacturing capabilities and supporting specialized healthcare technology solutions.

Stay tuned for more such updates on Digital Health News